Latest Period
Q1 2026
Security Snapshot
RESMED INC - Common Stock (RMD) Institutional Ownership
CUSIP: 761152107
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
929
Shares (Excl. Options)
96,634,845
Price
$224.48
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- RMD on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 96,634,845
- Total 13F value
- $21,684,275,321
- Portfolio coverage rank
- 0.01%
- Share change
- -433,087
- Value change
- -$137,359,693
- Number of holders
- 929
- Shares outstanding
- 145,776,137
- SEC-reported price per share
- $203.79
- Insider filing price
- $203.79
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- RMD - RESMED INC - Common Stock is tracked under CUSIP 761152107.
- 929 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 940 to 929 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $23,361,502,028 to $21,684,275,321.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 929 institutions filings for Q1 2026.
Security key
761152107
Latest holder period
Q1 2026
13F holders
929
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
RMD full holder history
RESMED INC SEC filings
RESMED INC company facts
RESMED INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 761152107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
RMD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 8.2% | $2,685,163,808 | 11,961,706 | Vanguard Capital Management | 31 Mar 2026 | |||
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.4% | $1,770,359,051 | 7,886,489 | Vanguard Portfolio Management | 31 Mar 2026 |
As of 31 Mar 2026, 929 institutional investors reported holding 96,634,845 shares of RESMED INC - Common Stock (RMD). This represents 66% of the company’s total 145,776,137 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
46%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.3% | 12,094,023 | -2.1% | 0.05% | $2,714,866,496 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 9,466,416 | 0% | 0.05% | $2,125,021,063 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.4% | 7,863,922 | 0% | 0.09% | $1,765,293,211 |
| STATE STREET CORP | 4.6% | 6,643,168 | +0.27% | 0.05% | $1,491,258,353 |
| Bank of New York Mellon Corp | 3.4% | 4,925,386 | +0.71% | 0.2% | $1,105,650,719 |
| GEODE CAPITAL MANAGEMENT, LLC | 3% | 4,352,873 | +1.2% | 0.06% | $973,793,098 |
| MORGAN STANLEY | 1.8% | 2,686,821 | -7.1% | 0.04% | $603,138,265 |
| Invesco Ltd. | 1.3% | 1,956,614 | +0.24% | 0.07% | $439,220,813 |
| NORTHERN TRUST CORP | 1.2% | 1,725,693 | -3.3% | 0.05% | $387,383,564 |
| FIRST TRUST ADVISORS LP | 1.1% | 1,537,825 | +1.3% | 0.25% | $345,210,958 |
| DEUTSCHE BANK AG\ | 0.98% | 1,422,865 | +0.66% | 0.11% | $319,404,735 |
| Swedbank AB | 0.93% | 1,350,234 | +22% | 0.32% | $303,100,529 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.78% | 1,135,299 | +2.9% | 0.04% | $254,851,920 |
| Amundi | 0.73% | 1,062,184 | +124% | 0.06% | $238,439,009 |
| NORDEA INVESTMENT MANAGEMENT AB | 0.71% | 1,033,381 | -4.8% | 0.21% | $227,033,806 |
| DIMENSIONAL FUND ADVISORS LP | 0.69% | 1,004,218 | +2.4% | 0.05% | $225,389,452 |
| GOLDMAN SACHS GROUP INC | 0.69% | 1,004,205 | +2.5% | 0.03% | $225,424,028 |
| Legal & General Group Plc | 0.68% | 990,361 | -0.22% | 0.05% | $222,316,237 |
| BANK OF AMERICA CORP /DE/ | 0.64% | 928,430 | +12% | 0.02% | $208,414,038 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.58% | 849,070 | +1.5% | 0.04% | $190,599,234 |
| VANGUARD FIDUCIARY TRUST CO | 0.57% | 825,076 | 0% | 0.05% | $185,213,060 |
| UBS Group AG | 0.5% | 726,811 | -20% | 0.03% | $163,154,533 |
| JPMORGAN CHASE & CO | 0.48% | 705,147 | +20% | 0.01% | $155,153,652 |
| Caisse de depot et placement du Quebec | 0.37% | 538,031 | +12% | 0.19% | $120,777,199 |
| CAPTRUST FINANCIAL ADVISORS | 0.33% | 487,861 | +1.6% | 0.19% | $109,509,874 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 96,634,845 | $21,684,275,321 | -$137,359,693 | $224.48 | 929 |
| 2025 Q4 | 96,981,394 | $23,361,502,028 | +$1,010,595,349 | $240.87 | 940 |
| 2025 Q3 | 91,805,254 | $25,120,556,319 | -$164,908,411 | $273.73 | 939 |
| 2025 Q2 | 92,309,428 | $23,802,163,537 | -$234,889,533 | $258.00 | 911 |
| 2025 Q1 | 93,341,270 | $20,873,665,746 | +$659,205,153 | $223.85 | 872 |
| 2024 Q4 | 90,103,150 | $20,611,027,939 | +$523,118,005 | $228.69 | 863 |
| 2024 Q3 | 86,823,807 | $21,178,183,309 | +$357,448,956 | $244.12 | 792 |
| 2024 Q2 | 85,413,001 | $16,344,246,847 | +$454,535,216 | $191.42 | 768 |
| 2024 Q1 | 82,914,769 | $16,411,147,126 | +$513,359,778 | $198.03 | 710 |
| 2023 Q4 | 80,394,822 | $13,829,283,421 | -$1,271,808,453 | $172.02 | 680 |
| 2023 Q3 | 87,735,817 | $12,964,369,891 | -$1,617,256,395 | $147.87 | 648 |
| 2023 Q2 | 95,075,328 | $20,771,183,152 | -$111,688,592 | $218.50 | 724 |
| 2023 Q1 | 95,323,306 | $20,870,559,574 | +$76,827,102 | $218.99 | 665 |
| 2022 Q4 | 95,570,997 | $19,893,153,622 | -$213,631,417 | $208.13 | 717 |
| 2022 Q3 | 96,528,325 | $21,085,043,390 | -$40,809,623 | $218.30 | 650 |
| 2022 Q2 | 96,423,808 | $20,247,886,410 | -$216,827,167 | $209.63 | 661 |
| 2022 Q1 | 97,272,612 | $23,607,128,509 | +$638,048,061 | $242.51 | 658 |
| 2021 Q4 | 94,533,097 | $24,611,319,237 | -$550,619,558 | $260.48 | 703 |
| 2021 Q3 | 96,265,199 | $25,370,506,829 | -$115,406,017 | $263.55 | 673 |
| 2021 Q2 | 96,700,199 | $23,835,730,320 | -$548,687,648 | $246.52 | 650 |
| 2021 Q1 | 99,033,646 | $19,213,495,080 | -$384,053,397 | $194.02 | 649 |
| 2020 Q4 | 101,297,957 | $21,523,684,165 | +$125,179,911 | $212.56 | 652 |
| 2020 Q3 | 100,513,676 | $17,230,325,953 | -$286,391,481 | $171.43 | 612 |
| 2020 Q2 | 102,006,987 | $19,585,421,181 | +$701,386,093 | $192.00 | 567 |
| 2020 Q1 | 98,435,082 | $14,502,972,264 | +$119,165,301 | $147.29 | 574 |